259 related articles for article (PubMed ID: 31274145)
1. Antithrombotic treatment and major adverse cardiac events after bleeding in patients with myocardial infarction: a retrospective analysis of nationwide registry data.
Nabi H; Rørth R; Tajchman DH; Holmvang L; Torp-Pedersen C; Gislason G; Fosbøl EL; Køber L; Sørensen R
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):14-21. PubMed ID: 31274145
[TBL] [Abstract][Full Text] [Related]
2. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839
[TBL] [Abstract][Full Text] [Related]
3. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.
Sørensen R; Hansen ML; Abildstrom SZ; Hvelplund A; Andersson C; Jørgensen C; Madsen JK; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
Lancet; 2009 Dec; 374(9706):1967-74. PubMed ID: 20006130
[TBL] [Abstract][Full Text] [Related]
4. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
6. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
8. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
[TBL] [Abstract][Full Text] [Related]
9. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
10. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
11. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
12. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
Karrowni W; Wang TY; Chen AY; Thomas L; Saucedo JF; El Accaoui RN
Heart; 2015 Feb; 101(4):264-70. PubMed ID: 25336230
[TBL] [Abstract][Full Text] [Related]
13. Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial.
Schwalm JD; Ahmad M; Salehian O; Eikelboom JW; Natarajan MK
J Thromb Thrombolysis; 2010 Aug; 30(2):127-32. PubMed ID: 20157843
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML
J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189
[TBL] [Abstract][Full Text] [Related]
15. Association of Antithrombotic Drug Use With Subdural Hematoma Risk.
Gaist D; García Rodríguez LA; Hellfritzsch M; Poulsen FR; Halle B; Hallas J; Pottegård A
JAMA; 2017 Feb; 317(8):836-846. PubMed ID: 28245322
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention.
Gao X; Ge Z; Kong X; Wang Z; Zuo G; Wang F; Chen S; Zhang J
Int Heart J; 2019 May; 60(3):546-553. PubMed ID: 31105152
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis.
Galli M; Andreotti F; D'Amario D; Vergallo R; Vescovo GM; Giraldi L; Migliaro S; Ameri P; Porto I; Crea F
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):43-56. PubMed ID: 31350546
[TBL] [Abstract][Full Text] [Related]
18. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.
van Rein N; Heide-Jørgensen U; Lijfering WM; Dekkers OM; Sørensen HT; Cannegieter SC
Circulation; 2019 Feb; 139(6):775-786. PubMed ID: 30586754
[TBL] [Abstract][Full Text] [Related]
19. Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation.
Sindet-Pedersen C; Staerk L; Lamberts M; Gerds TA; Berger JS; Nissen Bonde A; Langtved Pallisgaard J; Hansen ML; Torp-Pedersen C; Gislason GH; Bjerring Olesen J
Heart; 2018 Jun; 104(11):912-920. PubMed ID: 29092916
[TBL] [Abstract][Full Text] [Related]
20. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]